Guangzhou Wondfo Biotech Co Ltd
SZSE:300482
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Guangzhou Wondfo Biotech Co Ltd
SZSE:300482
|
CN |
|
O
|
OneLife Technologies Corp
OTC:OLMM
|
US |
|
Alkyl Amines Chemicals Ltd
NSE:ALKYLAMINE
|
IN |
|
T
|
Taiwan Chelic Co Ltd
TWSE:4555
|
TW |
|
China Tungsten and Hightech Materials Co Ltd
SZSE:000657
|
CN |
Wall Street
Price Targets
Price Targets Summary
Guangzhou Wondfo Biotech Co Ltd
According to Wall Street analysts, the average 1-year price target for
Guangzhou Wondfo Biotech Co Ltd
is 26.67 CNY
with a low forecast of 24.42 CNY and a high forecast of 31.59 CNY.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Guangzhou Wondfo Biotech Co Ltd's stock price target?
Price Target
26.67
CNY
According to Wall Street analysts, the average 1-year price target for
Guangzhou Wondfo Biotech Co Ltd
is 26.67 CNY
with a low forecast of 24.42 CNY and a high forecast of 31.59 CNY.
What is Guangzhou Wondfo Biotech Co Ltd's Revenue forecast?
Projected CAGR
3%
For the last 11 years the
compound annual growth rate for
Guangzhou Wondfo Biotech Co Ltd's revenue is
26%.
The projected
CAGR
for the next 3 years is
3%.
What is Guangzhou Wondfo Biotech Co Ltd's Operating Income forecast?
Projected CAGR
17%
For the last 11 years the
compound annual growth rate for
Guangzhou Wondfo Biotech Co Ltd's operating income is
27%.
The projected
CAGR
for the next 3 years is
17%.
What is Guangzhou Wondfo Biotech Co Ltd's Net Income forecast?
Projected CAGR
-1%
For the last 11 years the
compound annual growth rate for
Guangzhou Wondfo Biotech Co Ltd's net income is
23%.
The projected
CAGR
for the next 3 years is
-1%.
